These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 6166278)

  • 41. Antiviral and anti-invasive titers of human interferons.
    Ikić D; Beck M; Juzbasić M; Delimar N; Lulić V; Smerdel S; Jusić D; Rajninger-Miholić M; Ikić M
    Int J Clin Pharmacol Ther Toxicol; 1982 Apr; 20(4):179-80. PubMed ID: 6176564
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Antiviral effect of interferon on influenza virus infection in mice.
    Saito N; Suzuki F; Ishida N
    Tohoku J Exp Med; 1983 Apr; 139(4):355-63. PubMed ID: 6191407
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Inactivation of human interferon by body fluids.
    Cesario TC; Tilles JG
    Tex Rep Biol Med; 1977; 35():443-8. PubMed ID: 616673
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Circulating human interferon after intramuscular injection into animals and man.
    Cantell K; Pyhälä L; Strander H
    J Gen Virol; 1974 Dec; 25(3):453-5. PubMed ID: 4443796
    [No Abstract]   [Full Text] [Related]  

  • 45. Administration of human leukocyte interferon in herpes zoster. I. Safety, circulating, antiviral activity, and host responses to infection.
    Jordan GW; Fried RP; Merigan TC
    J Infect Dis; 1974 Jul; 130(1):56-62. PubMed ID: 4601181
    [No Abstract]   [Full Text] [Related]  

  • 46. Monoclonal antibodies against human fibroblast interferon.
    Hochkeppel HK; Menge U; Collins J
    Eur J Biochem; 1981 Sep; 118(3):437-42. PubMed ID: 6170512
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Antibody neutralization studies of the antiviral activities of human leukocyte interferon on different cells.
    Havell EA
    Arch Virol; 1980; 65(3-4):229-36. PubMed ID: 6158304
    [TBL] [Abstract][Full Text] [Related]  

  • 48. High-yield interferon induction by 10-carboxymethyl-9-acridanone in mice and hamsters.
    Taylor JL; Schoenherr CK; Grossberg SE
    Antimicrob Agents Chemother; 1980 Jul; 18(1):20-6. PubMed ID: 6158292
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effective antiviral prophylaxis and therapy by systemic application of human interferon in immunosuppressed monkeys.
    Neumann-Haefelin D; Shrestha B; Manthey KF
    J Infect Dis; 1976 Jun; 133 Suppl():A211-6. PubMed ID: 180202
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Concentration of heterogeneous leukocyte interferon].
    Solov'ev VD; Parfenov VV; Zubanova NA; Pokidysheva LN; Tkach TA
    Vopr Virusol; 1981; (6):720-4. PubMed ID: 6175114
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Distribution of interferon in body fluids and tissues.
    Bocci V
    Tex Rep Biol Med; 1977; 35():436-42. PubMed ID: 358467
    [No Abstract]   [Full Text] [Related]  

  • 52. IFN induction and associated changes in splenic leukocyte distribution.
    Ishikawa R; Biron CA
    J Immunol; 1993 May; 150(9):3713-27. PubMed ID: 7682583
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Method of increasing the activity of a preparation of human cadaver leukocyte interferon].
    Parfenov VV; Zubanova NA; Mekhedov LN; Pokidysheva LN; Kuznetsov VP
    Vopr Virusol; 1980; (3):294-7. PubMed ID: 6159731
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Study of the catabolism of interferon, using the isolated and perfused liver].
    Pessina GP; Pacini A; Bargigli V; Russi-Sorce M; Bocci V
    Boll Soc Ital Biol Sper; 1976 May; 52(10):651-7. PubMed ID: 949376
    [No Abstract]   [Full Text] [Related]  

  • 55. Target cells for interferon induction by BL-20803.
    Siminoff P
    J Infect Dis; 1976 Jun; 133 Suppl():A37-42. PubMed ID: 932505
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparison of the antiviral activities of various cloned human interferon-alpha subtypes in mammalian cell cultures.
    Weck PK; Apperson S; May L; Stebbing N
    J Gen Virol; 1981 Nov; 57(Pt 1):233-7. PubMed ID: 6172550
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pleural effusion disease in rabbits. Interferon in body fluids and tissues after experimental infection.
    Fennestad KL; Haahr S; Bruun L
    Acta Pathol Microbiol Scand B; 1979 Oct; 87(5):311-5. PubMed ID: 525355
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Characterization of antiviral activity of spotted souslik (Spermophilus suslicus) interferons.
    Kandefer-Szerszeń M
    Arch Immunol Ther Exp (Warsz); 1987; 35(4):489-99. PubMed ID: 2449874
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Rat leukocyte interferons: production of an acid-labile interferon after induction with Newcastle disease virus.
    Wiedbrauk DL; Burleson GR
    J Leukoc Biol; 1987 Jul; 42(1):21-9. PubMed ID: 2439625
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Antibody to staphylococcal enterotoxin A-induced human immune interferon (IFN gamma).
    Langford MP; Weigent DA; Georgiades JA; Johnson HM; Stanton GJ
    J Immunol; 1981 Apr; 126(4):1620-3. PubMed ID: 6162895
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.